Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.29 - $0.72 $317,152 - $787,412
-1,093,628 Reduced 98.85%
12,670 $4,000
Q4 2022

Feb 14, 2023

BUY
$0.42 - $0.78 $266,139 - $494,259
633,666 Added 134.07%
1,106,298 $498,000
Q3 2022

Nov 14, 2022

SELL
$0.92 - $1.75 $646,666 - $1.23 Million
-702,898 Reduced 59.79%
472,632 $416,000
Q2 2022

Aug 15, 2022

SELL
$0.96 - $1.91 $367,266 - $730,706
-382,569 Reduced 24.55%
1,175,530 $1.35 Million
Q1 2022

May 16, 2022

SELL
$1.6 - $3.35 $771,656 - $1.62 Million
-482,285 Reduced 23.64%
1,558,099 $2.73 Million
Q4 2021

Feb 14, 2022

BUY
$2.08 - $3.65 $4.15 Million - $7.28 Million
1,993,770 Added 4277.19%
2,040,384 $6.61 Million
Q3 2021

Nov 15, 2021

BUY
$1.35 - $4.01 $26,507 - $78,736
19,635 Added 72.78%
46,614 $187,000
Q2 2021

Aug 16, 2021

SELL
$1.48 - $1.92 $82,092 - $106,498
-55,468 Reduced 67.28%
26,979 $44,000
Q1 2021

May 17, 2021

SELL
$1.82 - $3.01 $21,943 - $36,291
-12,057 Reduced 12.76%
82,447 $157,000
Q4 2020

Feb 16, 2021

BUY
$1.49 - $2.37 $103,604 - $164,793
69,533 Added 278.46%
94,504 $213,000
Q3 2020

Nov 16, 2020

SELL
$1.68 - $2.17 $320,906 - $414,504
-191,016 Reduced 88.44%
24,971 $49,000
Q2 2020

Aug 14, 2020

BUY
$1.39 - $2.84 $300,221 - $613,403
215,987 New
215,987 $451,000
Q3 2019

Nov 14, 2019

SELL
$1.17 - $2.36 $62,993 - $127,064
-53,841 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$1.36 - $2.07 $63,080 - $96,012
46,383 Added 621.92%
53,841 $96,000
Q2 2019

Aug 14, 2019

BUY
$1.36 - $2.07 $10,142 - $15,438
7,458 New
7,458 $243,000
Q2 2018

Aug 14, 2018

SELL
$6.76 - $10.01 $85,919 - $127,227
-12,710 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$6.06 - $8.54 $77,022 - $108,543
12,710 New
12,710 $105,000
Q4 2017

Feb 14, 2018

SELL
$4.99 - $7.3 $110,383 - $161,483
-22,121 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$5.15 - $7.14 $113,923 - $157,943
22,121
22,121 $126,000

Others Institutions Holding LPTX

# of Institutions
1
Shares Held
265K
Call Options Held
0
Put Options Held
0

About LEAP THERAPEUTICS, INC.


  • Ticker LPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,021,400
  • Market Cap $198M
  • Description
  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...
More about LPTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.